Literature DB >> 25589785

Distinct requirements for HIV-cell fusion and HIV-mediated cell-cell fusion.

Naoyuki Kondo1, Mariana Marin1, Jeong Hwa Kim1, Tanay M Desai1, Gregory B Melikyan2.   

Abstract

Whether HIV-1 enters cells by fusing with the plasma membrane or with endosomes is a subject of active debate. The ability of HIV-1 to mediate fusion between adjacent cells, a process referred to as "fusion-from-without" (FFWO), shows that this virus can fuse with the plasma membrane. To compare FFWO occurring at the cell surface with HIV-cell fusion through a conventional entry route, we designed an experimental approach that enabled the measurements of both processes in the same sample. The following key differences were observed. First, a very small fraction of viruses fusing with target cells participated in FFWO. Second, whereas HIV-1 fusion with adherent cells was insensitive to actin inhibitors, post-CD4/coreceptor binding steps during FFWO were abrogated. A partial dependence of HIV-cell fusion on actin remodeling was observed in CD4(+) T cells, but this effect appeared to be due to the actin dependence of virus uptake. Third, deletion of the cytoplasmic tail of HIV-1 gp41 dramatically enhanced the ability of the virus to promote FFWO, while having a modest effect on virus-cell fusion. Distinct efficiencies and actin dependences of FFWO versus HIV-cell fusion are consistent with the notion that, except for a minor fraction of particles that mediate fusion between the plasma membranes of adjacent cells, HIV-1 enters through an endocytic pathway. We surmise, however, that cell-cell contacts enabling HIV-1 fusion with the plasma membrane could be favored at the sites of high density of target cells, such as lymph nodes.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cytoskeleton; Endocytosis; Fluorescence; Membrane Fusion; Plasma Membrane

Mesh:

Substances:

Year:  2015        PMID: 25589785      PMCID: PMC4358289          DOI: 10.1074/jbc.M114.623181

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

1.  Localization of CD4 and CCR5 in living cells.

Authors:  Carolyn M Steffens; Thomas J Hope
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 2.  Sorting out the cellular functions of sorting nexins.

Authors:  Carolyn A Worby; Jack E Dixon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-12       Impact factor: 94.444

3.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.

Authors:  Marielle Cavrois; Carlos De Noronha; Warner C Greene
Journal:  Nat Biotechnol       Date:  2002-09-30       Impact factor: 54.908

4.  Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton.

Authors:  Paul U Cameron; Suha Saleh; Georgina Sallmann; Ajantha Solomon; Fiona Wightman; Vanessa A Evans; Genevieve Boucher; Elias K Haddad; Rafick-Pierre Sekaly; Andrew N Harman; Jenny L Anderson; Kate L Jones; Johnson Mak; Anthony L Cunningham; Anthony Jaworowski; Sharon R Lewin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

5.  Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.

Authors:  Akihito Yonezawa; Marielle Cavrois; Warner C Greene
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.

Authors:  S A Gallo; A Puri; R Blumenthal
Journal:  Biochemistry       Date:  2001-10-16       Impact factor: 3.162

7.  Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions.

Authors:  James M Binley; Charmagne S Cayanan; Cheryl Wiley; Norbert Schülke; William C Olson; Dennis R Burton
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells.

Authors:  Minoru Tobiume; Janet E Lineberger; Christopher A Lundquist; Michael D Miller; Christopher Aiken
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis.

Authors:  V Maréchal; M C Prevost; C Petit; E Perret; J M Heard; O Schwartz
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 10.  The HIV Env-mediated fusion reaction.

Authors:  Stephen A Gallo; Catherine M Finnegan; Mathias Viard; Yossef Raviv; Antony Dimitrov; Satinder S Rawat; Anu Puri; Stewart Durell; Robert Blumenthal
Journal:  Biochim Biophys Acta       Date:  2003-07-11
View more
  20 in total

1.  SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.

Authors:  Chetan Sood; Mariana Marin; Ajit Chande; Massimo Pizzato; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

Review 2.  Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs.

Authors:  Tiffany A Peterson; Andrew G MacLean
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-13       Impact factor: 4.147

3.  Cell-cell and virus-cell fusion assay-based analyses of alanine insertion mutants in the distal α9 portion of the JRFL gp41 subunit from HIV-1.

Authors:  Mizuki Yamamoto; Qingling Du; Jiping Song; Hongyun Wang; Aya Watanabe; Yuetsu Tanaka; Yasushi Kawaguchi; Jun-Ichiro Inoue; Zene Matsuda
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

4.  Differential binding of the HIV-1 envelope to phosphatidylserine receptors.

Authors:  Linlin Gu; Brian Sims; Alexandre Krendelchtchikov; Edlue Tabengwa; Qiana L Matthews
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-06-13       Impact factor: 3.747

5.  P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.

Authors:  Charline Giroud; Mariana Marin; Jason Hammonds; Paul Spearman; Gregory B Melikyan
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

6.  Screening and Functional Profiling of Small-Molecule HIV-1 Entry and Fusion Inhibitors.

Authors:  Charline Giroud; Yuhong Du; Mariana Marin; Qui Min; Nathan T Jui; Haian Fu; Gregory B Melikyan
Journal:  Assay Drug Dev Technol       Date:  2017 Feb/Mar       Impact factor: 1.738

7.  HIV-1 gp41 transmembrane oligomerization monitored by FRET and FCS.

Authors:  Sabrina Schroeder; Joshua D Kaufman; Matthias Grunwald; Peter J Walla; Nils-Alexander Lakomek; Paul T Wingfield
Journal:  FEBS Lett       Date:  2018-03-05       Impact factor: 4.124

8.  Single-cell glycolytic activity regulates membrane tension and HIV-1 fusion.

Authors:  Charles A Coomer; Irene Carlon-Andres; Maro Iliopoulou; Michael L Dustin; Ewoud B Compeer; Alex A Compton; Sergi Padilla-Parra
Journal:  PLoS Pathog       Date:  2020-02-21       Impact factor: 6.823

9.  Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters.

Authors:  Yen-Cheng Chen; Chetan Sood; Mariana Marin; Jesse Aaron; Enrico Gratton; Khalid Salaita; Gregory B Melikyan
Journal:  ACS Nano       Date:  2020-06-01       Impact factor: 15.881

10.  Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.

Authors:  Xuening Wang; Chih-Hsiung Chen; Saiaditya Badeti; Jong Hyun Cho; Alireza Naghizadeh; Ziren Wang; Dongfang Liu
Journal:  Cell Biosci       Date:  2021-06-23       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.